CG Oncology IPO prices above range and boosts share count in bullish move ahead of trading

Cancer drug company CG Oncology Inc. priced its initial public offering above its estimated range and added three million shares to the deal in a bullish sign ahead of its trading debut Thursday on t…

https://www.marketwatch.com/story/cg-oncology-ipo-prices-above-range-and-boosts-share-count-in-bullish-move-ahead-of-trading-0b32a66a